- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-1801
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study ; volume:2 ; number:1 ; day:22 ; month:9 ; year:2013 ; pages:1-5 ; date:12.2013
SpringerPlus ; 2, Heft 1 (22.9.2013), 1-5, 12.2013
- Urheber
-
Edvardsson, Bengt
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/2193-1801-2-479
- URN
-
urn:nbn:de:1111-2016032728145
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Edvardsson, Bengt
- SpringerLink (Online service)
Ähnliche Objekte (12)
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study
Efficacy of the Digital Therapeutic sinCephalea in the prophylaxis of migraine in patients with episodic migraine: study protocol for a digital, randomized, open-label, standard treatment controlled trial
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
The sense of stopping migraine prophylaxis
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study
Riboflavin prophylaxis in pediatric and adolescent migraine
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study
Galcanezumab in patients with episodic migraine: results from the open-label period of the phase 3 PERSIST study
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study
Efficacy of the Digital Therapeutic sinCephalea in the prophylaxis of migraine in patients with episodic migraine: study protocol for a digital, randomized, open-label, standard treatment controlled trial
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
The sense of stopping migraine prophylaxis
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study
Riboflavin prophylaxis in pediatric and adolescent migraine
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study
Galcanezumab in patients with episodic migraine: results from the open-label period of the phase 3 PERSIST study
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study
Efficacy of the Digital Therapeutic sinCephalea in the prophylaxis of migraine in patients with episodic migraine: study protocol for a digital, randomized, open-label, standard treatment controlled trial
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
The sense of stopping migraine prophylaxis
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study
Riboflavin prophylaxis in pediatric and adolescent migraine
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study
Galcanezumab in patients with episodic migraine: results from the open-label period of the phase 3 PERSIST study
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study